Vacunación en la Enfermedad Pulmonar Obstructiva Crónica: Bibliografía

Bibliografía

• 1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(suppl):S77-S120.
• 2. European Respiratory Society. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995;8:1398-1420.
• 3. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990;11:555-69.
• 4. Anthonisen NR, Wright EC, Hodgkin JE, and the IPPB Trial Group. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20.
• 5. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15 year follow-up study. Am Rev Respir Dis 1979;119:895-902.
• 6. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977;1:1645-8.
• 7. Burrows B. Predictors of loss of lung function in obstructive lung disease. Eur Respir Rev 1991;1:340-5.
• 8. Murphy TF, Sethi S. State of the art. Bacterial infection on chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146:1067-83.
• 9. Derenne JP, Fleury B, Pariente R. Acute respiratory failure of chronic obstructive pulmonary disease. Am Rev Respir Dis 1988;138:1006-33.
• 10. Schmidt GA, Hall JB. Acute or chronic respiratory failure. Assesssment and management of patients with COPD in the emergent setting. JAMA 1989;261:3444-53.
• 11. Snider GL, Failing LJ, Rennard SI. Chronic bronchitis and emphysema. In: Murray JF, Nadel JA, eds. Texbook of Respiratory Medicine. Second Edition. Philadelphia: WB Saunders Co; 1994:1331-97.
• 12. Sherman CB, Osmanski J, Hudson LD. Acute exacerbations in COPD patients. In: Cherniak NS, de. Chronic obstructive pulmonary disease. Philadelphia: WB Saunders Co; 1991:443-55.
• 13. Busho RO, Saxtan D, Schultz PS, et als. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis 1978;137:377-83.
• 14. Monto AS. Epidemiology of respiratory viruses in persons with and without asthma and COPD. Am J Respir Crit Care Med 1995;151:1653-8.
• 15. Chodosh S. Treatment of acute exacerbation of chronic bronchitis: State of the art. Am J Med 1991;91:87s-92s.
• 16. Monto AS, Higgins MW, Ross HW. The Tecumseh study of respiratory illness. VIII: acute infection in chronic respiratory disease. Am Rev Respir Dis 1975;111:27-36.
• 17. Wiselka M. Influenza: diagnosis, management, and prophylaxis. Br Med J 1994; 308:1341-5.
• 18. Nicolson KG. Clinical features of influenza. Semin Resp Infect 1992;7:26-37.
• 19. Rothbarth PH, Kempen BM, Sprenger MJW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:1682-6.
• 20. Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Respir Dis 1990;142:1004-8.
• 21. Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204.
• 22. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from october 1972 to May 1985. Am J Public Health 1987;77:712-6.
• 23. Monto AS. Influenza: quantifying morbidity and mortality. Am J Med 1987;82:20-5.
• 24. Patriarca PA, Weber JA, Parker A, Hall WN, Kendal AP, Bregman DJ. Efficacy of influenza vaccine in nursing homes: reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985;253:1136-9.
• 25. Gross PA, Quinnan GV, Rodstein M, et al. Association of influenza immunization with reduction in mortality in an elderly population. Arch Intern Med 1988;148:562-5.
• 26. Saah AJ, Neufeld R, Rodstein M, et al. Influenza vaccine and pneumonia mortality in a nursing home population. Arch Intern Med 1986;146:2353-7.
• 27. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982;142:85-9.
• 28. Fedson DS, Wadja A, Nicol JP, Hammond GW, Kaiser DL, Ross LL. Clinical effectiveness od influenza vaccination in Mannitoba. JAMA 1993;270:1956-61.
• 29. Foster DA, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296-307.
• 30. Govaert TME, Thijs CTMCN, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-5.
• 31. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84).
• 32. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-527.
• 33. Paul WS, Cowen J, Jackson GG. Acute respiratory illness among immunized and non-immunized patients with high risk factors during a split season of influenza A and B. J Infect Dis 1988;157:633-9.
• 34. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA 1990;264:1139-41.
• 35. Govaert TME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people: randomized double blind placebo-controlled trial. Br Med J 1993;307:988-90.
• 36. Griffith DE, Mazurek GH. Pneumonia and chronic obstructive lung disease. Infect Dis Clin North Am 1991; 5:467-84.
• 37. Fedson DS. Pneumococcal vaccination in the prevention of community acquired pneumoniae: an optimistic view of cost-effectiveness. Semin Respir Infect 1993;8:285-93.
• 38. Centers dor Disease Control and Prevention. Update on adult immunization. Recommendations of the immunization practices advisory committee (ACIP). MMWR, 1993:42
• 39. American College of Physicians. Pneumococcal vaccine recommendations. Ann Intern Med 1982;96:206-7.
• 40. Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980;303:549-52.
• 41. Clemens JD, Shapiro DE. Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials ? Rev Infect Dis 1984;6:589-600.
• 42. Bolan G, Broome CV, Facklam RR, Plikaytis BD, Fraser DW, Schlech WF. Pneumococcal vaccine efficacy in select populationsin the United States. Ann Intern Med 1986;104:1-6.
• 43. Simberkoff MS, Cross AP, Al-Brahim M, et al. Efficaccy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315:1318-27.
• 44. Shapiro DE. Pneumococcal vaccine failure. N Engl J Med 1987;316:1272-3.
• 45. Forrester HL, Jahnigen DW, LaForce PM. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med 1987; 83:425-30.
• 46. Sims RV, Steinmann WC, McConville JH, King LK, Zwick WC, Schwartz IS. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988;108:653-7 (Erratum, Ann Intern Med 1988;109:762-3).
• 47. Shapiro ED, Clemens JD. A controlled evaluation of protective efficacy of pneumococcal vaccine for patients at high risk for serious pneumococcal infections. Ann Intern Med 1984;101:325-30.
• 48. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, Detsky AS, Kapoor WN. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154: 2666 – 77.
• 49. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, Adair RK, Clemens JD. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
• 50. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826-31.
• 51. Sisk JE, Riegelman RK. Cost effectiveness of vaccination against pneumococcal pneumonia. Ann Intern Med 1986; 104: 79-86.
• 52. Brignoli C, Sedory-Holzer S, et al. Pneumococal vaccine. Efficacy and associated cost savings. JAMA 1990; 264: 2910 -5.
• 53. Honkanen PO, Keistinen T, Kivela SL. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med 1996;156:205-8.
• 54. Centers for Disease Control and Prevention. Update: influenze activity-United States and worlwide, 1995-96 season, and composition of the 1996-97 influenza vaccine. JAMA 1996;275:1467-8.
• 55. Ministerio de Salud – Instituto Nacional de Salud. Informe Quincenal Epidemiológico Nacional. Epidemia de influenza A/H3N2 en Colombia, agosto a octubre de 1996. IQEN 1996;1:4-6.
• 56. Dueñas CC, Chaparro MC, Boshell SJ. Etiología viral de la neumonía adquirida en la comunidad. Acta Med Colomb 1992; 17(abs):314.
• 57. Dueñas CC, Chaparro MC, Boshell SJ. Etiología infecciosa de las exacerbaciones de EPOC. Acta Med Colomb 1992; 17 (abs): 319.
• 58. Chaparro C, Ortega H, Torres C, Giraldo H. Neumonía adquirida en la comunidad. Rev Colomb Neumol 1989; 1:17-24.
• 59. Robledo J, Sierra P, Londoño A, et al. Estudio etiológico de las neumonías adquiridas en la comunidad. Resúmenes VII Congreso Panamericano de Infectología, 1995:(abs)122.
• 60. Instituto Nacional de Salud – Proyecto Nacional de Serotipificación de S. pneumoniae. Mortalidad por Streptococcus pneumoniae en niños con neumonía en Santa Fe de Bogotá, Medellín y Cali, 1994-1995. Análisis preliminar. Boletín epidemiológico – INS 1995;3:53-7.
• 61. Torres CA, Fernández L, Ruíz A. Neumonía bacterémica por S. pneumoniae. Acta Med Colomb 1992;17(abs):319.
• 62. Castillo O, Leal AL, Gama ME, Arango M, Calle M, Castañeda E. Infecciones invasivas en niños causadas por streptococcus pneumoniae en Santa Fe de Bogotá. Resúmenes VII Congreso Panamericano de Infectología 1995: (abs) 99.
• 63. Guzmán M, Sánchez P. Frecuencia y distribución de serotipos de Streptococcus pneumoniae en Santa Fe de Bogotá, Colombia. Resúmenes VII Congreso Panamericano de Infectología 1995;(abs):133.
• 64. Instituto Nacional de Salud – Proyecto Nacional de Serotipificación de S. pneumoniae. Serotipos y susceptibilidad antimicrobiana de cepas invasivas de Streptococcus pneumoniae en Colombia. Resúmenes VII Congreso Panamericano de Infectología 1995;(abs):133.
• 65. Torres CA. Vacunación en la Enfermedad Pulmonar Obstructiva Crónica. Rev Colomb Neumol 1997 ;9 :133-7.